Seer stock reports leadership change as revenue falls 23 percent

Published on 10/07/2026 at 01:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Seer stock was last at USD 2.19 on October 6, 2026, while the company completed a finance leadership transition. Second-quarter revenue fell to USD 3.1 million.

SEER, US81578P1066, Illustration mit AI erstellt.

Seer, Inc. (ISIN US81578P1066) was last at USD 2.19 on Nasdaq on October 6, 2026, down 6.01 percent from the prior close. The company completed a finance leadership transition on October 1, while second-quarter revenue fell 23 percent year over year to USD 3.1 million.

Finance leadership has changed

According to StockTitan, David Horn resigned as Seer's president, chief financial officer and treasurer effective October 1, 2026, to pursue other interests.

Omid Farokhzad, already chief executive officer and board chair, became president, while Charles Endweiss took over as treasurer and principal financial and accounting officer. The filing said Horn's resignation was not related to a disagreement over operations.

Revenue pressure remains visible

Seer's second-quarter 2026 revenue was USD 3.1 million, compared with USD 4.1 million in the second quarter of 2025. StockTitan reported gross profit of USD 1.5 million and a 49 percent gross margin for the quarter.

The net loss improved to USD 16.9 million from USD 19.4 million a year earlier, while operating expenses declined to USD 18.3 million from USD 22.6 million. Seer reaffirmed its fiscal-year 2026 revenue outlook of USD 16 million to USD 18 million.

Peptide and Protein reported that first-half 2026 revenue reached USD 5.9 million, down 29 percent from USD 8.3 million in the first half of 2025. The company ended June 30, 2026 with USD 209.5 million in cash, equivalents and investments.

Analyst target stands above the stock

MarketScreener showed a Buy consensus from one analyst and an average target of USD 4.00. That target lies 82.65 percent above the USD 2.19 Nasdaq price on October 6, 2026.

The valuation gap puts commercial execution beside leadership continuity as the central investor question. Seer's Proteograph platform had appeared in more than 80 peer-reviewed publications, while its stated 2026 revenue midpoint of USD 17 million implies low single-digit growth against the prior year.

Seer stock stays near its yearly high

At USD 2.19 on October 6, 2026, Seer stock was 9.13 percent below its 52-week high of USD 2.41 and 41.29 percent above its 52-week low of USD 1.55. The session range was USD 2.18 to USD 2.35, with volume of 144,327 shares.

The market capitalization was USD 120.4 million as of October 6, 2026. The combination of a cash-rich balance sheet, lower quarterly operating expenses and a 23 percent revenue decline leaves the next results update as the key test of the reaffirmed outlook.